ReviewMolecules (Basel, Switzerland)2026

Exploiting Methyl Triazenes as Attractive Alternatives to Temozolomide and Dacarbazine for Cancer Therapy.

Goreti Ribeiro Morais et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.